Gregory F. Heath
Directeur/Bestuurslid bij numares AG
Profiel
Gregory F.
Heath is a Member-Supervisory Board at numares AG since 2022.
Previously, he worked as Head-Business Development at F.
Hoffmann-La Roche Ltd.
from 2000 to 2003, Senior VP-Global Molecular Diagnostics Business at Roche Molecular Systems, Inc. from 2004 to 2008, and Senior VP & General Manager-Diagnostics at Illumina, Inc. in 2011.
He holds a graduate degree from Hollins University Corp., an undergraduate degree from Illinois State University, and a doctorate degree from Virginia Commonwealth University.
Actieve functies van Gregory F. Heath
| Bedrijven | Functie | Begin |
|---|---|---|
numares AG
 numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | Directeur/Bestuurslid | 01-01-2022 |
Eerdere bekende functies van Gregory F. Heath
| Bedrijven | Functie | Einde |
|---|---|---|
Roche Molecular Systems, Inc.
 Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Corporate Officer/Principal | 01-01-2008 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 02-01-2003 |
| ILLUMINA, INC. | Corporate Officer/Principal | - |
Opleiding van Gregory F. Heath
| Illinois State University | Undergraduate Degree |
| Hollins University Corp. | Graduate Degree |
| Virginia Commonwealth University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ILLUMINA, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Health Services |
numares AG
numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | Health Technology |
